Biolife solutions secures strategic customer wins and plans 2022 expansion in $400 million biostorage services market

Bothell, wash. , march 15, 2022 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today provided additional details on its growth expectations for the company's scisafe®  biostorage services platform.
BLFS Ratings Summary
BLFS Quant Ranking